Broken String Biosciences
Genomics & Genetic Testing · Cell & Gene Therapy
$15Mtotal raised · 9 rounds on record
Venture roundlatest round · Oct 2025 · 12 mo ago
3backers · DvH Ventures, Illumina Ventures
50+team · employees, estimated range
Overview
The next generation of genome-wide on- and off-target analysis in your own hands. Our INDUCE-seq platform provides precise off-target detection and genome-wide insights.
Key facts
These are the key facts about Broken String Biosciences on Alion as of Nov 13, 2026. Broken String Biosciences is headquartered in Saffron Walden, United Kingdom. It was founded in 2020. The latest round is Series A of $15M, announced in 2023.
- Headquarters
- Saffron Walden, United KingdomAlion company profile, updated Nov 13, 2026
- Founded
- 2020Alion company profile, updated Nov 13, 2026
- Employees
- 50+Alion company profile, an estimated range
- Total raised
- $15MSum of 1 equity round Alion knows
- Latest round
- Series A · $15M · Sep 18, 2023Press report · businesswire.com
Official records
Funding and backers
Total raised
$15M
9 rounds on record
Latest round
Venture round
Oct 2025 · 12 mo ago
Team
51-200
employees, estimated range
Backers
3
DvH Ventures, Illumina Ventures
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 11
Launched Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development · NewsMedical
Jun 16
Board appointment Broken String Biosciences Appoints Bruce Eaton PhD as Chairman of the Board · morningstar.com
Mar 31
Renamed Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide off-target analysis · NewsMedical
Oct 31, 2025
Raised a round Venture round
Jul 18, 2025
Raised a round Venture round
Feb 6, 2025
Raised a round Venture round
Oct 7, 2024
Raised a round Venture round
Mar 31, 2024
Raised a round Venture round
Sep 18, 2023
Raised a round Series A $15M
Aug 7, 2023
Raised a round Venture round
Sep 7, 2021
Raised a round Venture round
Mar 24, 2021
Raised a round Venture round
Jan 23, 2020
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jul 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Feb 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Oct 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Mar 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Series A | Sep 2023 | $15M | — | businesswire.com |
| Venture round | Aug 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Sep 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Mar 2021 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | BROKEN STRING BIOSCIENCES LIMITED | Companies House |
| Registered | 23 Jan 2020 |
Backed byfrom the funds' portfolios and accelerator catalogs
DvH Ventures 
Mérieux Equity Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…
At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.
Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding.
0 Built to find what cancer is hiding. What we believe No patient should miss a treatment opportunity because the right biomarker could not…
Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome…
IconPCR with AutoNorm gives you normalized, sequencing-ready NGS libraries in one step, with real-time per-well control for 16S…
Financials
Total raised
$15M
Latest round
Venture - Series Unknown
Funding rounds
9
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Series A | 2023 | $15M | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development
Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the launch of BaseMap ABE. Built on the Company's INDUCE-seq technology, BaseMap ABE exten
Read more
Report
Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide off-target analysis
Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of its strategic repositioning.
Read more
Report
Broken String Biosciences Rebrands to Reflect Strategic Evolution as Demand Grows for Unbiased Genome-wide Off-target Analysis
CAMBRIDGE, England, March 31, 2026--Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of its
Read more
Report
Broken String Biosciences Rebrands to Reflect Strategic Evolution as Demand Grows for Unbiased Genome-wide Off-target Analysis
Read more
Report
Report
Broken String Biosciences and BioLizard to Develop AI for Faster, Safer Gene Editing
BOSTON & CHICAGO & CAMBRIDGE, England, July 10, 2025--Broken String Biosciences, a leader in advancing gene editing safety, and BioLizard, an expert in scientific data analytics and AI, today announced the development of SafeGuide, an AI tool for selectin
Read more
Report
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Saffron Walden
United Kingdom
HQ
50-200 est. staff
Chesterford Research Park Saffron Walden, England, CB10 1XL United Kingdom
How to cite this page
Alion, "Broken String Biosciences: key facts", as of Nov 13, 2026. https://alion.io/company/brokenstringbio
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0